Cyclerion therapeutics, inc. (CYCN)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18
ASSETS
Current assets:
Cash and cash equivalents

67,096

94,895

117,034

141,030

-

-

Related party accounts receivable

1,026

1,474

1,440

1,857

-

-

Prepaid expenses

1,868

1,966

2,164

1,778

927

867

Other current assets

136

2,862

68

28

12

12

Total current assets

70,126

101,197

120,706

144,693

939

879

Restricted cash

4,991

4,991

-

-

-

-

Restricted cash

-

-

7,726

7,726

-

-

Property and equipment, net

11,600

11,613

12,114

12,754

8,815

6,497

Operating lease right-of-use asset

52,254

68,137

69,158

70,330

-

-

Other assets

1,059

540

-

-

19

25

Total assets

140,030

186,478

209,704

235,503

9,773

7,401

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

1,463

3,230

4,818

6,863

5,671

2,781

Related party accounts payable

59

81

187

1,920

-

-

Accrued research and development costs

2,682

2,198

3,543

5,250

6,243

5,261

Accrued expenses and other current liabilities

4,563

9,320

7,298

7,017

-

9,804

Current portion of operating lease liabilities

2,668

3,420

3,250

866

-

-

Accrued expenses and other current liabilities

-

-

-

-

5,559

-

Total current liabilities

11,435

18,249

19,096

21,916

17,473

17,846

Operating lease liabilities, net of current portion

47,055

70,500

71,411

72,397

-

-

Stockholders' equity
Accumulated deficit

-105,855

-85,627

-59,572

-32,254

-

-

Net parent investment

-

-

-

-

-

10,445

Paid-in capital

187,413

183,376

178,768

173,448

-

-

Accumulated other comprehensive loss

-18

-20

1

-4

-

-

Other liabilities

-

-

-

-

52

-

Total stockholders' equity

81,540

97,729

119,197

141,190

-7,752

-10,445

Total liabilities and stockholders' equity

140,030

186,478

209,704

235,503

9,773

7,401